nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Alzheimer's disease—Parkinson's disease	0.68	1	CtDrD
Donepezil—HTR2A—Parkinson's disease	0.128	0.522	CbGaD
Donepezil—CYP2D6—Parkinson's disease	0.117	0.478	CbGaD
Donepezil—HTR2A—enteric nervous system—Parkinson's disease	0.00289	0.0971	CbGeAlD
Donepezil—HRH3—hindbrain—Parkinson's disease	0.00221	0.0742	CbGeAlD
Donepezil—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00219	0.0736	CbGeAlD
Donepezil—Tetrabenazine—SLC18A2—Parkinson's disease	0.00212	0.599	CrCbGaD
Donepezil—HTR2A—locus ceruleus—Parkinson's disease	0.00191	0.0641	CbGeAlD
Donepezil—HTR2A—cerebellar cortex—Parkinson's disease	0.00156	0.0522	CbGeAlD
Donepezil—HTR2A—sympathetic nervous system—Parkinson's disease	0.00151	0.0507	CbGeAlD
Donepezil—HRH3—brainstem—Parkinson's disease	0.00127	0.0425	CbGeAlD
Donepezil—HRH3—forebrain—Parkinson's disease	0.00122	0.041	CbGeAlD
Donepezil—HTR2A—pons—Parkinson's disease	0.0011	0.0369	CbGeAlD
Donepezil—HTR2A—autonomic nervous system—Parkinson's disease	0.00102	0.0341	CbGeAlD
Donepezil—HTR2A—telencephalic ventricle—Parkinson's disease	0.000906	0.0304	CbGeAlD
Donepezil—HTR2A—peripheral nervous system—Parkinson's disease	0.000732	0.0246	CbGeAlD
Donepezil—HRH3—head—Parkinson's disease	0.0007	0.0235	CbGeAlD
Donepezil—HRH3—nervous system—Parkinson's disease	0.000664	0.0223	CbGeAlD
Donepezil—Tetrabenazine—DRD2—Parkinson's disease	0.000654	0.185	CrCbGaD
Donepezil—HRH3—central nervous system—Parkinson's disease	0.000639	0.0214	CbGeAlD
Donepezil—HRH3—cerebellum—Parkinson's disease	0.000625	0.021	CbGeAlD
Donepezil—HTR2A—nerve—Parkinson's disease	0.000571	0.0192	CbGeAlD
Donepezil—HRH3—brain—Parkinson's disease	0.000508	0.017	CbGeAlD
Donepezil—ACHE—medulla oblongata—Parkinson's disease	0.000478	0.016	CbGeAlD
Donepezil—Tetrabenazine—CYP2D6—Parkinson's disease	0.000462	0.131	CrCbGaD
Donepezil—ACHE—midbrain—Parkinson's disease	0.000437	0.0147	CbGeAlD
Donepezil—HTR2A—hindbrain—Parkinson's disease	0.000428	0.0143	CbGeAlD
Donepezil—ACHE—spinal cord—Parkinson's disease	0.000426	0.0143	CbGeAlD
Donepezil—CYP2D6—hindbrain—Parkinson's disease	0.00039	0.0131	CbGeAlD
Donepezil—ACHE—cerebellum—Parkinson's disease	0.000338	0.0113	CbGeAlD
Donepezil—SIGMAR1—medulla oblongata—Parkinson's disease	0.000321	0.0108	CbGeAlD
Donepezil—SIGMAR1—midbrain—Parkinson's disease	0.000293	0.00983	CbGeAlD
Donepezil—SIGMAR1—spinal cord—Parkinson's disease	0.000286	0.00959	CbGeAlD
Donepezil—ACHE—brain—Parkinson's disease	0.000275	0.00921	CbGeAlD
Donepezil—HTR2A—embryo—Parkinson's disease	0.000267	0.00897	CbGeAlD
Donepezil—HTR2A—brainstem—Parkinson's disease	0.000245	0.00822	CbGeAlD
Donepezil—CYP2C9—cardiovascular system—Parkinson's disease	0.000243	0.00815	CbGeAlD
Donepezil—HTR2A—forebrain—Parkinson's disease	0.000237	0.00793	CbGeAlD
Donepezil—SIGMAR1—cerebellum—Parkinson's disease	0.000227	0.00761	CbGeAlD
Donepezil—CYP2D6—brainstem—Parkinson's disease	0.000223	0.00749	CbGeAlD
Donepezil—CYP2D6—forebrain—Parkinson's disease	0.000216	0.00723	CbGeAlD
Donepezil—HTR2A—cardiovascular system—Parkinson's disease	0.0002	0.00671	CbGeAlD
Donepezil—SIGMAR1—brain—Parkinson's disease	0.000184	0.00618	CbGeAlD
Donepezil—Doxazosin—CYP2D6—Parkinson's disease	0.000177	0.05	CrCbGaD
Donepezil—HTR2A—medulla oblongata—Parkinson's disease	0.000171	0.00573	CbGeAlD
Donepezil—HTR2A—midbrain—Parkinson's disease	0.000156	0.00524	CbGeAlD
Donepezil—HTR2A—spinal cord—Parkinson's disease	0.000152	0.00511	CbGeAlD
Donepezil—HTR2A—head—Parkinson's disease	0.000135	0.00454	CbGeAlD
Donepezil—HTR2A—nervous system—Parkinson's disease	0.000128	0.00431	CbGeAlD
Donepezil—Doxazosin—ABCB1—Parkinson's disease	0.000126	0.0357	CrCbGaD
Donepezil—HTR2A—central nervous system—Parkinson's disease	0.000124	0.00415	CbGeAlD
Donepezil—CYP2D6—head—Parkinson's disease	0.000123	0.00414	CbGeAlD
Donepezil—HTR2A—cerebellum—Parkinson's disease	0.000121	0.00405	CbGeAlD
Donepezil—CYP3A4—nervous system—Parkinson's disease	0.000119	0.00399	CbGeAlD
Donepezil—CYP2D6—nervous system—Parkinson's disease	0.000117	0.00392	CbGeAlD
Donepezil—CYP3A4—central nervous system—Parkinson's disease	0.000114	0.00384	CbGeAlD
Donepezil—CYP2D6—central nervous system—Parkinson's disease	0.000113	0.00378	CbGeAlD
Donepezil—CYP2D6—cerebellum—Parkinson's disease	0.00011	0.00369	CbGeAlD
Donepezil—HTR2A—brain—Parkinson's disease	9.82e-05	0.00329	CbGeAlD
Donepezil—CYP2D6—brain—Parkinson's disease	8.94e-05	0.003	CbGeAlD
Donepezil—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	2.81e-05	0.000687	CbGpPWpGaD
Donepezil—ACHE—Metabolism—FBP1—Parkinson's disease	2.79e-05	0.000682	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GBA—Parkinson's disease	2.79e-05	0.000682	CbGpPWpGaD
Donepezil—ACHE—Metabolism—DBH—Parkinson's disease	2.79e-05	0.000682	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	2.79e-05	0.000681	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.77e-05	0.000678	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGF20—Parkinson's disease	2.76e-05	0.000673	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.75e-05	0.000672	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	2.71e-05	0.000661	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GRK5—Parkinson's disease	2.69e-05	0.000656	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADORA2A—Parkinson's disease	2.67e-05	0.000653	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EDN1—Parkinson's disease	2.66e-05	0.00065	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR2A—Parkinson's disease	2.56e-05	0.000626	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	2.55e-05	0.000623	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HTR1A—Parkinson's disease	2.53e-05	0.000619	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.5e-05	0.000611	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—TAC1—Parkinson's disease	2.5e-05	0.000609	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—INSR—Parkinson's disease	2.47e-05	0.000603	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD1—Parkinson's disease	2.45e-05	0.000598	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GRK5—Parkinson's disease	2.44e-05	0.000595	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GRM4—Parkinson's disease	2.41e-05	0.000588	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD3—Parkinson's disease	2.37e-05	0.000579	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGB—Parkinson's disease	2.33e-05	0.00057	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—COMT—Parkinson's disease	2.33e-05	0.000569	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR2A—Parkinson's disease	2.33e-05	0.000568	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR1A—Parkinson's disease	2.32e-05	0.000567	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	2.32e-05	0.000567	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	2.31e-05	0.000565	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—COMT—Parkinson's disease	2.31e-05	0.000564	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	2.3e-05	0.000562	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	2.3e-05	0.000561	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.3e-05	0.000561	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	2.29e-05	0.00056	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VPS35—Parkinson's disease	2.29e-05	0.00056	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	2.29e-05	0.000559	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TAC1—Parkinson's disease	2.29e-05	0.000558	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PENK—Parkinson's disease	2.28e-05	0.000557	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	2.28e-05	0.000557	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	2.27e-05	0.000554	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	2.25e-05	0.00055	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD1—Parkinson's disease	2.24e-05	0.000547	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GRM4—Parkinson's disease	2.19e-05	0.000534	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD3—Parkinson's disease	2.17e-05	0.00053	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HTR7—Parkinson's disease	2.14e-05	0.000523	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD2—Parkinson's disease	2.14e-05	0.000523	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	2.13e-05	0.000521	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	2.11e-05	0.000516	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	2.1e-05	0.000513	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PDYN—Parkinson's disease	2.09e-05	0.00051	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	2.08e-05	0.000509	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PENK—Parkinson's disease	2.07e-05	0.000506	CbGpPWpGaD
Donepezil—ACHE—Metabolism—DDC—Parkinson's disease	2.05e-05	0.000501	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	2.04e-05	0.000498	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	2.04e-05	0.000497	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRBK1—Parkinson's disease	2.03e-05	0.000495	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.01e-05	0.000491	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	1.98e-05	0.000484	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR7—Parkinson's disease	1.96e-05	0.000479	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD2—Parkinson's disease	1.96e-05	0.000479	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GRM5—Parkinson's disease	1.94e-05	0.000474	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTA4—Parkinson's disease	1.94e-05	0.000473	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.91e-05	0.000467	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GPR37—Parkinson's disease	1.9e-05	0.000464	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DGKQ—Parkinson's disease	1.9e-05	0.000464	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PDYN—Parkinson's disease	1.9e-05	0.000463	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	1.84e-05	0.000449	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	1.83e-05	0.000446	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.82e-05	0.000444	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	1.81e-05	0.000443	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GRM5—Parkinson's disease	1.76e-05	0.00043	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLA2G6—Parkinson's disease	1.74e-05	0.000426	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP1R1B—Parkinson's disease	1.74e-05	0.000424	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MAOB—Parkinson's disease	1.73e-05	0.000421	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—EDN1—Parkinson's disease	1.72e-05	0.000419	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	1.65e-05	0.000403	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF2—Parkinson's disease	1.65e-05	0.000402	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.64e-05	0.000401	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.59e-05	0.000389	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF1R—Parkinson's disease	1.59e-05	0.000388	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EDN1—Parkinson's disease	1.57e-05	0.000384	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—COMT—Parkinson's disease	1.52e-05	0.000372	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RIT2—Parkinson's disease	1.52e-05	0.000371	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	1.52e-05	0.00037	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	1.51e-05	0.00037	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MCCC1—Parkinson's disease	1.51e-05	0.000369	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ND3—Parkinson's disease	1.51e-05	0.000369	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	1.5e-05	0.000367	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADORA2A—Parkinson's disease	1.5e-05	0.000366	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ND3—Parkinson's disease	1.5e-05	0.000366	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MCCC1—Parkinson's disease	1.5e-05	0.000366	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	1.5e-05	0.000365	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	1.48e-05	0.000361	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NGF—Parkinson's disease	1.44e-05	0.000353	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRK5—Parkinson's disease	1.44e-05	0.000352	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HTR1A—Parkinson's disease	1.43e-05	0.00035	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.42e-05	0.000347	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—OMD—Parkinson's disease	1.42e-05	0.000347	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—TAC1—Parkinson's disease	1.41e-05	0.000344	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—OMD—Parkinson's disease	1.41e-05	0.000344	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TALDO1—Parkinson's disease	1.41e-05	0.000344	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.39e-05	0.00034	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	1.38e-05	0.000338	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.37e-05	0.000336	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR2A—Parkinson's disease	1.37e-05	0.000336	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.35e-05	0.000329	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	1.34e-05	0.000327	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	1.34e-05	0.000326	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	1.3e-05	0.000318	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	1.29e-05	0.000315	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.29e-05	0.000314	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP2D6—Parkinson's disease	1.28e-05	0.000313	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	1.28e-05	0.000313	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APOE—Parkinson's disease	1.28e-05	0.000312	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCH1—Parkinson's disease	1.27e-05	0.000311	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CTGF—Parkinson's disease	1.26e-05	0.000307	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	1.26e-05	0.000307	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.25e-05	0.000305	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAG—Parkinson's disease	1.22e-05	0.000299	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PENK—Parkinson's disease	1.22e-05	0.000299	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	1.22e-05	0.000297	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—INS—Parkinson's disease	1.21e-05	0.000296	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	1.21e-05	0.000296	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	1.21e-05	0.000296	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.19e-05	0.000292	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP2E1—Parkinson's disease	1.17e-05	0.000286	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NQO1—Parkinson's disease	1.16e-05	0.000283	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.15e-05	0.000281	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GBA—Parkinson's disease	1.15e-05	0.00028	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.15e-05	0.00028	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DBH—Parkinson's disease	1.15e-05	0.00028	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TH—Parkinson's disease	1.14e-05	0.000279	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	1.14e-05	0.000277	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GBA—Parkinson's disease	1.14e-05	0.000277	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.14e-05	0.000277	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DBH—Parkinson's disease	1.14e-05	0.000277	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	1.12e-05	0.000273	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	1.1e-05	0.000269	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	1.1e-05	0.000269	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYCS—Parkinson's disease	1.1e-05	0.000268	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—INS—Parkinson's disease	1.09e-05	0.000267	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	1.05e-05	0.000257	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	1.04e-05	0.000254	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MCCC1—Parkinson's disease	9.88e-06	0.000241	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ND3—Parkinson's disease	9.88e-06	0.000241	CbGpPWpGaD
Donepezil—ACHE—Metabolism—COMT—Parkinson's disease	9.72e-06	0.000237	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	9.7e-06	0.000237	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—Parkinson's disease	9.67e-06	0.000236	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MAOA—Parkinson's disease	9.65e-06	0.000236	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—Parkinson's disease	9.54e-06	0.000233	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TALDO1—Parkinson's disease	9.29e-06	0.000227	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—OMD—Parkinson's disease	9.29e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	9.24e-06	0.000226	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—Parkinson's disease	9.16e-06	0.000224	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	9.13e-06	0.000223	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—Parkinson's disease	8.89e-06	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	8.85e-06	0.000216	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	8.81e-06	0.000215	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	8.81e-06	0.000215	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX1—Parkinson's disease	8.51e-06	0.000208	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DDC—Parkinson's disease	8.41e-06	0.000205	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCH1—Parkinson's disease	8.4e-06	0.000205	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DDC—Parkinson's disease	8.34e-06	0.000204	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—INSR—Parkinson's disease	8.17e-06	0.0002	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—Parkinson's disease	8.13e-06	0.000199	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—Parkinson's disease	8.08e-06	0.000197	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA4—Parkinson's disease	7.94e-06	0.000194	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA4—Parkinson's disease	7.87e-06	0.000192	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTHFR—Parkinson's disease	7.86e-06	0.000192	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.77e-06	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGB—Parkinson's disease	7.72e-06	0.000189	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	7.68e-06	0.000188	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	7.57e-06	0.000185	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FBP1—Parkinson's disease	7.49e-06	0.000183	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DBH—Parkinson's disease	7.49e-06	0.000183	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GBA—Parkinson's disease	7.49e-06	0.000183	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK8—Parkinson's disease	7.47e-06	0.000182	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	7.42e-06	0.000181	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—Parkinson's disease	7.31e-06	0.000179	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	7.19e-06	0.000175	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	7.15e-06	0.000175	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	7.09e-06	0.000173	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.08e-06	0.000173	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MAOB—Parkinson's disease	7.02e-06	0.000171	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.71e-06	0.000164	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.68e-06	0.000163	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	6.5e-06	0.000159	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	6.5e-06	0.000159	CbGpPWpGaD
Donepezil—ACHE—Metabolism—INS—Parkinson's disease	6.25e-06	0.000153	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DDC—Parkinson's disease	5.5e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	5.45e-06	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	5.27e-06	0.000129	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	5.22e-06	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	5.2e-06	0.000127	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.19e-06	0.000127	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.16e-06	0.000126	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CTGF—Parkinson's disease	5.12e-06	0.000125	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.81e-06	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NGF—Parkinson's disease	4.78e-06	0.000117	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—Parkinson's disease	4.77e-06	0.000117	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	4.77e-06	0.000116	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.76e-06	0.000116	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NQO1—Parkinson's disease	4.72e-06	0.000115	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TH—Parkinson's disease	4.69e-06	0.000114	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.68e-06	0.000114	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TH—Parkinson's disease	4.65e-06	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.63e-06	0.000113	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.5e-06	0.00011	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYCS—Parkinson's disease	4.46e-06	0.000109	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.23e-06	0.000103	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—COMT—Parkinson's disease	3.99e-06	9.73e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.97e-06	9.69e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.96e-06	9.67e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—COMT—Parkinson's disease	3.95e-06	9.65e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—Parkinson's disease	3.93e-06	9.6e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MAOA—Parkinson's disease	3.92e-06	9.58e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.91e-06	9.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—Parkinson's disease	3.88e-06	9.47e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.76e-06	9.17e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—Parkinson's disease	3.72e-06	9.09e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.65e-06	8.9e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.62e-06	8.83e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—Parkinson's disease	3.62e-06	8.83e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.49e-06	8.53e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—Parkinson's disease	3.46e-06	8.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.44e-06	8.4e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.38e-06	8.24e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.22e-06	7.87e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.19e-06	7.8e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.15e-06	7.68e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.11e-06	7.59e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TH—Parkinson's disease	3.07e-06	7.49e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—Parkinson's disease	3e-06	7.33e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—Parkinson's disease	2.97e-06	7.26e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.94e-06	7.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.69e-06	6.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.67e-06	6.53e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COMT—Parkinson's disease	2.61e-06	6.36e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.59e-06	6.33e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.59e-06	6.32e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—INS—Parkinson's disease	2.56e-06	6.26e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.56e-06	6.25e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—INS—Parkinson's disease	2.54e-06	6.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.47e-06	6.04e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.46e-06	6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.38e-06	5.82e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.28e-06	5.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.11e-06	5.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—Parkinson's disease	1.96e-06	4.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—INS—Parkinson's disease	1.68e-06	4.09e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.58e-06	3.86e-05	CbGpPWpGaD
